AWA Point
Author: Inga-Lill Andersson
The life sciences patent maze – USA
ON MARCH 4, 2014, the US Patent Office issued new guidelines on how to evaluate the patentability of inventions
Report from BIO 2013 in Chicago
On April 22-25, 2013, the yearly BIO International Convention was held in Chicago. This is the largest global event
New dosage regimen may be patented, but no more Swiss-type claims
The Enlarged Board of Appeal of the EPO clarifies, in decision G 2/08 of 19 February 2010, that it
Centocor (Johnson & Johnson) awarded the largest patent verdict in U.S. history
1.67 billion U.S. dollars, $1.16 billion in lost profit, and $504 million in royalties. That’s what Centocor is awarded
What are the consequences of the decision from the Federal Circuit on the new USPTO regulations?
In August 2007 the United States Patent and Trademark Office (USPTO) issued a rules package intended to limit the
No conflict between scientific research and commercialisation
It’s a widely held myth in the world of medical research that patent is a dirty word, merely a
BIO International Convention – a dazzling experience
“Innovate, heal, fuel, feed the world” – that is the theme of BIO 2008, the world’s largest convention for biotech,